ASCENDIS PHARMA A/S's ticker is ASND and the CUSIP is 04351P101. A total of 164 filers reported holding ASCENDIS PHARMA A/S in Q2 2023. The put-call ratio across all filers is 0.63 and the average weighting 0.5%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ENVESTNET ASSET MANAGEMENT INC | 4,882 | $435,719 | 0.00% |
| FOSTER DYKEMA CABOT & CO INC/MA | 22 | $2 | 0.00% |
| Citadel Advisors | 18,400 | $1,642,200 | 0.00% |
| WELLS FARGO & COMPANY/MN | 10,819 | $965,556 | 0.00% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 14,634 | $1,306,085 | 0.00% |
| ROYAL BANK OF CANADA | 10,013 | $894,000 | 0.00% |
| BARCLAYS PLC | 608 | $54 | 0.00% |
| Quent Capital, LLC | 27 | $2,410 | 0.00% |
| SIMPLEX TRADING, LLC | 5,364 | $478 | 0.00% |
| Washington Trust Advisors, Inc. | 38 | $3,392 | 0.00% |
| Bogart Wealth, LLC | 34 | $3,035 | 0.00% |
| Financial Gravity Asset Management, Inc. | 89 | $47 | 0.00% |
| PEAK6 Investments LLC | 500 | $44,625 | 0.00% |
| Cutler Group LLC / CA | 400 | $0 | 0.00% |
External links
This page lists ASCENDIS PHARMA A/S's shareholders in Q2 2023. To view ASCENDIS PHARMA A/S's shareholder history, click here.